Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
Clinical trial NCT02588339 · COMPLETED
Trial details
- NCT number
- NCT02588339
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-04
- Primary completion
- 2018-12-07
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.